VolitionRx Limited Repayments of Long-Term Debt
VolitionRx Limited (VNRX) reported Repayments of Long-Term Debt of $426.61 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-13
- VolitionRx Limited repayments of long-term debt for the quarter ending 2026-06-30 was $180.42K, a 12.72% increase year-over-year.
- VolitionRx Limited repayments of long-term debt for the quarter ending 2026-03-31 was $246.19K, a 2.21% decline year-over-year.
- VolitionRx Limited repayments of long-term debt for the quarter ending 2025-12-31 was $180.38K, a 29.54% decline year-over-year.
- VolitionRx Limited repayments of long-term debt for the quarter ending 2025-09-30 was $285.35K, a 5.14% decline year-over-year.
- VolitionRx Limited repayments of long-term debt for fiscal 2025 was $877.55K, a 19.31% decline from fiscal 2024.
- VolitionRx Limited repayments of long-term debt for fiscal 2024 was $1.09M, a 10.83% increase from fiscal 2023.
- VolitionRx Limited repayments of long-term debt for fiscal 2023 was $981.29K, a 22.63% decline from fiscal 2022.
- VolitionRx Limited repayments of long-term debt for fiscal 2022 was $1.27M.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 9 month as first filed | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $180.42K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $426.61K 10-Q · filed 2026-08-13 | $606.98K derived: sum of 3 quarters · filed 2026-08-13 | $892.33K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2026-03-31 | $246.19K 10-Q · filed 2026-05-14 | $426.56K derived: sum of 2 quarters · filed 2026-05-14 | $711.91K derived: sum of 3 quarters · filed 2026-05-14 | $871.98K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-12-31 | $180.38K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $465.73K derived: sum of 2 quarters · filed 2026-03-31 | $625.79K derived: sum of 3 quarters · filed 2026-08-13 | $877.55K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $285.35K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $445.42K derived: sum of 2 quarters · filed 2026-08-13 | $697.17K 10-Q · filed 2025-11-13 | $953.18K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-06-30 | $160.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $411.82K 10-Q · filed 2026-08-13 | $667.83K derived: sum of 3 quarters · filed 2026-08-13 | $968.64K derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $251.76K 10-Q · filed 2026-05-14 | $507.77K derived: sum of 2 quarters · filed 2026-05-14 | $808.58K derived: sum of 3 quarters · filed 2026-05-14 | $1.13M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $256.01K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $556.82K derived: sum of 2 quarters · filed 2026-03-31 | $877.37K derived: sum of 3 quarters · filed 2026-03-31 | $1.09M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $300.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $621.36K derived: sum of 2 quarters · filed 2025-11-13 | $831.54K 10-Q · filed 2025-11-13 | $1.13M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $320.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $530.73K 10-Q · filed 2025-08-14 | $831.70K derived: sum of 3 quarters · filed 2025-08-14 | $1.04M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $210.18K 10-Q · filed 2025-05-15 | $511.15K derived: sum of 2 quarters · filed 2025-05-15 | $715.51K derived: sum of 3 quarters · filed 2025-05-15 | $968.13K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $300.97K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $505.33K derived: sum of 2 quarters · filed 2025-03-31 | $757.95K derived: sum of 3 quarters · filed 2025-03-31 | $981.29K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $204.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $456.99K derived: sum of 2 quarters · filed 2024-11-14 | $680.33K 10-Q · filed 2024-11-14 | $1.01M derived: sum of 4 quarters · filed 2024-11-14 | |
| 2023-06-30 | $252.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $475.96K 10-Q · filed 2024-08-14 | $802.49K derived: sum of 3 quarters · filed 2024-08-14 | $1.11M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $223.34K 10-Q · filed 2024-05-13 | $549.87K derived: sum of 2 quarters · filed 2024-05-13 | $860.06K derived: sum of 3 quarters · filed 2024-05-13 | $1.24M derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $326.53K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $636.72K derived: sum of 2 quarters · filed 2024-03-25 | $1.02M derived: sum of 3 quarters · filed 2024-03-25 | $1.27M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $310.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $691.15K derived: sum of 2 quarters · filed 2023-11-14 | $941.86K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $380.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $631.67K 10-Q · filed 2023-08-14 | |||
| 2022-03-31 | $250.71K 10-Q · filed 2023-05-10 | ||||
| 2020-06-30 | -$118.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$234.17K 10-Q · filed 2020-08-13 | -$322.52K derived: sum of 3 quarters · filed 2020-08-13 | -$437.76K derived: sum of 4 quarters · filed 2020-08-13 | |
| 2020-03-31 | -$115.88K 10-Q · filed 2020-05-07 | -$204.23K derived: sum of 2 quarters · filed 2020-05-07 | -$319.47K derived: sum of 3 quarters · filed 2020-05-07 | -$379.32K derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-12-31 | -$88.35K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | -$203.59K derived: sum of 2 quarters · filed 2020-02-20 | -$263.43K derived: sum of 3 quarters · filed 2020-08-13 | -$351.01K 10-K · filed 2020-02-20 | |
| 2019-09-30 | -$115.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$175.08K derived: sum of 2 quarters · filed 2020-08-13 | -$262.66K 10-Q · filed 2019-11-12 | -$329.53K derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-06-30 | -$59.84K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$147.42K 10-Q · filed 2020-08-13 | -$214.29K derived: sum of 3 quarters · filed 2020-08-13 | ||
| 2019-03-31 | -$87.58K 10-Q · filed 2020-05-07 | -$154.45K derived: sum of 2 quarters · filed 2020-05-07 | |||
| 2018-12-31 | -$66.87K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | -$436.78K 10-K · filed 2020-02-20 | |||
| 2018-09-30 | -$369.92K 10-Q · filed 2019-11-12 | $369.92K 10-Q · filed 2018-11-07 | |||
| 2017-09-30 | $29.81K 10-Q · filed 2018-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |